Theseus Pharmaceuticals Inc (THRX) Ownership

13.69 ↑0.30 (2.24%)
As of February 3, 2023, 3:59pm EST.

Institutional Ownership

Orbimed Advisors, LLC is the biggest individual institutional holder of Theseus Pharmaceuticals Inc (THRX), owning a total of 17 million shares. Combined, the top 23 institutional holders of THRX own 87.07% of the company with a total of 33.7 million shares.

In the latest ownership report on September 30th 2022, the top 23 institutional holders decreased their combined ownership of THRX by 109 thousand shares. 7 institutions bought 464,837 total additional shares and increased their ownership by an average of 116.74%. However 4 institutions sold 573,856 total shares and decreased their ownership by an average of 13.42%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Theseus Pharmaceuticals decreased by a net total of -109,019 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Orbimed Advisors, LLC44.020%0.000%17,041,66802022-09-30
FMR Inc12.407%-7.334%4,803,240-380,1232022-09-30
Foresite Capital Management V, LLC8.616%0.000%3,335,34602022-09-30
T. Rowe Price Associates, Inc.3.569%-0.274%1,381,489-3,7942022-09-30
Foresite Capital Opportunity Management V, LLC2.478%0.000%959,27502022-09-30
Boxer Capital LLC2.304%0.000%892,05702022-09-30
BlackRock Inc2.003%12.836%775,59088,2312022-09-30
Omega Fund Management LLC1.838%0.000%711,47902022-09-30
Vanguard Group Inc1.617%-0.536%625,943-3,3712022-09-30
Nextech Invest AG1.579%0.000%611,31002022-09-30
Rock Springs Capital Management LP1.130%0.000%437,32902022-09-30
Geode Capital Management, LLC0.742%12.203%287,39531,2562022-09-30
State Street Corporation0.641%6.152%248,28114,3882022-09-30
Woodline Partners LP0.611%11.671%236,39024,7062022-09-30
Farallon Capital Management, L.L.C.0.576%-45.536%223,149-186,5682022-09-30
Opaleye Management Inc0.570%583.127%220,650188,3502022-09-30
LAURION CAPITAL MANAGEMENT LP0.464%0.000%179,61902022-09-30
Wellington Management Company LLP0.446%186.869%172,566112,4112022-09-30
Ensign Peak Advisors Inc0.368%0.000%142,59802022-09-30
Northern Trust Corp0.345%4.291%133,5555,4952022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Orbimed Advisors, LLC44.020%0.000%17,041,66802022-09-30
FMR Inc12.407%-7.334%4,803,240-380,1232022-09-30
Foresite Capital Management V, LLC8.616%0.000%3,335,34602022-09-30
T. Rowe Price Associates, Inc.3.569%-0.274%1,381,489-3,7942022-09-30
Foresite Capital Opportunity Management V, LLC2.478%0.000%959,27502022-09-30
Boxer Capital LLC2.304%0.000%892,05702022-09-30
BlackRock Inc2.003%12.836%775,59088,2312022-09-30
Omega Fund Management LLC1.838%0.000%711,47902022-09-30
Vanguard Group Inc1.617%-0.536%625,943-3,3712022-09-30
Nextech Invest AG1.579%0.000%611,31002022-09-30
Rock Springs Capital Management LP1.130%0.000%437,32902022-09-30
Geode Capital Management, LLC0.742%12.203%287,39531,2562022-09-30
State Street Corporation0.641%6.152%248,28114,3882022-09-30
Woodline Partners LP0.611%11.671%236,39024,7062022-09-30
Farallon Capital Management, L.L.C.0.576%-45.536%223,149-186,5682022-09-30
Opaleye Management Inc0.570%583.127%220,650188,3502022-09-30
LAURION CAPITAL MANAGEMENT LP0.464%0.000%179,61902022-09-30
Wellington Management Company LLP0.446%186.869%172,566112,4112022-09-30
Ensign Peak Advisors Inc0.368%0.000%142,59802022-09-30
Northern Trust Corp0.345%4.291%133,5555,4952022-09-30
TD Asset Management Inc0.276%59.308%106,94839,8152022-06-30
Tekla Capital Management LLC0.258%0.000%100,00002022-06-30
Dafna Capital Management LLC0.212%2.215%81,8991,7752022-06-30

Mutual Fund Ownership

Fidelity® Select Biotechnology is the biggest individual fund holder of Theseus Pharmaceuticals Inc (THRX), owning a total of 1.9 million shares. Combined, the top 24 mutual fund holders of THRX own 19.70% of the company with a total of 7.6 million shares.

In the latest ownership report on December 31st 2022, the top 24 fund holders decreased their combined ownership of THRX by 10 thousand shares. None of the mutual funds bought any additional shares. However 3 funds sold 10,150 total shares and decreased their ownership by an average of 4.06%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Theseus Pharmaceuticals decreased by a net total of -10,150 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv1.049%0.000%405,97302022-12-31
Vanguard Extended Market Index Investor0.391%-0.291%151,357-4422022-12-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.195%-10.720%75,375-9,0502022-12-31
NT R2000 Value Index Fund - NL0.145%-1.159%56,100-6582022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Fidelity® Select Biotechnology4.799%0.000%1,857,89102022-11-30
T. Rowe Price Health Sciences2.786%-1.211%1,078,695-13,2262022-09-30
Fidelity Advisor® Biotechnology I2.131%-15.097%824,835-146,6722022-09-30
Fidelity® Select Health Care1.550%0.000%600,00002022-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr1.049%0.000%405,97302022-09-30
Vanguard Total Stock Mkt Idx Inv1.049%0.000%405,97302022-12-31
Fidelity Advisor® Health Care I1.033%0.000%400,00002022-11-30
Fidelity® Series Small Cap Opps0.905%-27.541%350,381-133,1752022-10-31
iShares Russell 2000 ETF0.796%-0.836%308,291-2,6002022-12-30
iShares Russell 2000 Value ETF0.449%0.000%173,77102022-12-30
Vanguard Extended Market Index Investor0.391%-0.291%151,357-4422022-12-31
Fidelity® Stock Selector Small Cap0.359%-29.224%139,146-57,4542022-10-31
Fidelity® Small Cap Index0.324%0.000%125,44902022-10-31
Fidelity Growth Compy Commingled Pl 30.288%-10.333%111,644-12,8652022-09-30
TD Health Sciences - I0.276%0.000%106,94802022-06-30
Fidelity® VIP Health Care Initial0.207%0.000%80,00002022-11-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.195%-10.720%75,375-9,0502022-12-31
Fidelity® Extended Market Index0.192%0.000%74,48302022-11-30
Fidelity® Growth Company0.188%-18.295%72,798-16,3002022-09-30
Tekla Healthcare Investors0.178%0.000%69,00002022-06-30
NT R2000 Value Index Fund - NL0.145%-1.159%56,100-6582022-12-31
T. Rowe Price Health Sciences Port0.138%0.000%53,47502022-09-30
NT R2000 Index Fund - NL0.134%8.438%51,8174,0322022-09-30
Fidelity® Stock Selec All Cp0.133%0.881%51,5414502022-11-30

Discussions

Please log in or register to share your thoughts.